Filtros de búsqueda

Lista de obras de A Semke

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia

artículo científico publicado en 2020

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia.

artículo científico publicado en 2015

Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia

scientific article published on 22 April 2020

Association of polymorphic variants of <i>GRIN2A</i> and <i>GRIN2B</i> genes with alcohol and tobacco abuse in patients with schizophrenia

artículo científico publicado en 2022

Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia

artículo científico publicado en 2014

Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome

scientific article published on 10 September 2020

CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects

artículo científico publicado en 2016

Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.

artículo científico publicado en 2017

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia

scientific article published on 22 April 2020

Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility

artículo científico publicado en 2015

Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia

artículo científico publicado en 2022

DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia

artículo científico publicado en 2015

Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia

artículo científico publicado en 2014

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.

artículo científico publicado en 2017

Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients

scientific article published on 15 June 2018

Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.

artículo científico publicado en 2016

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

artículo científico publicado en 2012

No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia.

artículo científico publicado en 2012

Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.

artículo científico publicado en 2016

Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy

artículo científico publicado en 2015

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.

artículo científico publicado en 2009

[An effect of quetiapine on the immune system of patients with schizophrenia]

artículo científico publicado en 2016

[Antibodies to native and denatured DNA in the serum of patients with schizophrenia depending on the clinical features of the disease]

artículo científico publicado en 2016

[Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics]

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda